Catalio Capital Management

Basecamp Research builds biological AI models from genomic data to help design therapeutics, including protein-based medicines.

Superluminal Medicines combines structural biology, protein dynamics, machine learning and experimental testing to discover small-molecule drugs for difficult G protein-coupled receptor targets. Its pipeline focuses on endocrine and cardiometabolic diseases, including rare genetic and hypothalamic obesity.